Cambridge Investment Research Advisors’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-9,083
| Closed | -$1.05M | – | 3349 |
|
2023
Q3 | $1.05M | Sell |
9,083
-714
| -7% | -$82.6K | ﹤0.01% | 1542 |
|
2023
Q2 | $1.01M | Sell |
9,797
-3,609
| -27% | -$371K | ﹤0.01% | 1609 |
|
2023
Q1 | $1.46M | Sell |
13,406
-1,251
| -9% | -$137K | 0.01% | 1330 |
|
2022
Q4 | $1.67M | Sell |
14,657
-1,571
| -10% | -$179K | 0.01% | 1183 |
|
2022
Q3 | $1M | Buy |
16,228
+1,804
| +13% | +$112K | 0.01% | 1477 |
|
2022
Q2 | $1.15M | Sell |
14,424
-1,213
| -8% | -$96.7K | 0.01% | 1375 |
|
2022
Q1 | $1.65M | Sell |
15,637
-3,741
| -19% | -$394K | 0.01% | 1258 |
|
2021
Q4 | $2.09M | Buy |
19,378
+924
| +5% | +$99.6K | 0.01% | 1121 |
|
2021
Q3 | $2.02M | Sell |
18,454
-2,298
| -11% | -$252K | 0.01% | 1092 |
|
2021
Q2 | $1.94M | Buy |
+20,752
| New | +$1.94M | 0.01% | 1141 |
|
2021
Q1 | – | Sell |
-8,605
| Closed | -$629K | – | 3035 |
|
2020
Q4 | $629K | Buy |
8,605
+3,234
| +60% | +$236K | ﹤0.01% | 1614 |
|
2020
Q3 | $417K | Buy |
+5,371
| New | +$417K | ﹤0.01% | 1724 |
|
2020
Q2 | – | Sell |
-10,463
| Closed | -$310K | – | 2550 |
|
2020
Q1 | $310K | Buy |
+10,463
| New | +$310K | ﹤0.01% | 1663 |
|